Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor γ Activation Pathway in Gastric Cancer

Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity

(2012) Thomas P. Burris et al.   CHEMISTRY & BIOLOGY

PPAR agonists for the treatment of cardiovascular disease in patients with diabetes

(2012) J. P. H. Wilding   DIABETES OBESITY & METABOLISM

Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders

(2012) Yu-Chang Chen et al.   MOLECULAR NEUROBIOLOGY

Quercetin Increased the Antiproliferative Activity of Green Tea Polyphenol (-)-Epigallocatechin Gallate in Prostate Cancer Cells

(2012) Piwen Wang et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Chemoprevention for gastric cancer

(2011) Alexander C. Ford   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway

(2011) Chern Chiuh Woo et al.   BIOCHEMICAL PHARMACOLOGY

PPARs and angiogenesis: Figure 1

(2011) David Bishop-Bailey   BIOCHEMICAL SOCIETY TRANSACTIONS

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells

(2011) Radhamani Kannaiyan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Isorhamnetin Suppresses Skin Cancer through Direct Inhibition of MEK1 and PI3-K

(2011) J.-E. Kim et al.   Cancer Prevention Research

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy

(2011) P N Kelly et al.   CELL DEATH AND DIFFERENTIATION

PPARs and their Effects on the Cardiovascular System

(2011) Adebayo Oyekan   CLINICAL AND EXPERIMENTAL HYPERTENSION

Natural polyphenols in cancer therapy

(2011) Miguel Asensi et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Mechanisms of cancer cell metastasis to the bone: a multistep process

(2011) Lalit R Patel et al.   Future Oncology

Recent advances in understanding the antibacterial properties of flavonoids

(2011) T.P. Tim Cushnie et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

(2011) Yoshihito Yokoyama et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Dietary Flavonoids as Cancer Prevention Agents

(2011) HUA YAO et al.   JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS

Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice

(2011) Muthu K. Shanmugam et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapy

(2011) Ajaya Kumar Reka et al.   LUNG CANCER

Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits β-catenin-mediated glioma cell growth and invasion

(2011) Zhengqiang Wan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4

(2011) Kanjoormana Manu et al.   Molecular Cancer

Peroxisome Proliferator-Activated Receptors Modulate Proliferation and Angiogenesis in Human Endometrial Carcinoma

(2011) M. Nickkho-Amiry et al.   MOLECULAR CANCER RESEARCH

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

The Nuclear Hormone Receptor PPARγas a Therapeutic Target in Major Diseases

(2011) Martina Victoria Schmidt et al.   TheScientificWorldJOURNAL

Effects of quercetin on the apoptosis of the human gastric carcinoma cells

(2011) Ping Wang et al.   TOXICOLOGY IN VITRO

RXRγ and PPARγ ligands in combination to inhibit proliferation and invasiveness in colon cancer cells

(2010) Alessio Papi et al.   CANCER LETTERS

Inhibitory effects of quercetin on aflatoxin B1-induced hepatic damage in mice

(2010) K.-C. Choi et al.   FOOD AND CHEMICAL TOXICOLOGY

Clinical Aspects of Gastric Cancer and Helicobacter pylori- Screening, Prevention, and Treatment

(2010) Michael Selgrad et al.   HELICOBACTER

Upregulation of PPARγ in Tissue with Gastric Carcinoma

(2010) Liping Yao et al.   HYBRIDOMA

The Flavonol Isorhamnetin Exhibits Cytotoxic Effects on Human Colon Cancer Cells

(2010) Sara Jaramillo et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells

(2010) Massimo Mannelli et al.   NEUROENDOCRINOLOGY

Repression of NHE1 Expression by PPAR  Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo

(2009) A. P. Kumar et al.   CANCER RESEARCH

Gastric cancer

(2008) P. Lochhead et al.   BRITISH MEDICAL BULLETIN

Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis

(2008) Hyo-Jung Lee et al.   CANCER LETTERS

Chemotherapy for metastatic gastric cancer: past, present, and future

(2008) Atsushi Ohtsu   JOURNAL OF GASTROENTEROLOGY

A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores

(2008) John C Boik et al.   BMC Pharmacology & Toxicology